These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9502644)

  • 1. High failure rate for an epicardial implantable cardioverter-defibrillator lead: implications for long-term follow-up of patients with an implantable cardioverter-defibrillator.
    Brady PA; Friedman PA; Trusty JM; Grice S; Hammill SC; Stanton MS
    J Am Coll Cardiol; 1998 Mar; 31(3):616-22. PubMed ID: 9502644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comparative Study of Defibrillator Leads at a Large-Volume Implanting Hospital: Results From the Pacemaker and Implantable Defibrillator Leads Survival Study ("PAIDLESS").
    Cohen TJ; Asheld WJ; Germano J; Islam S; Patel D
    J Invasive Cardiol; 2015 Jun; 27(6):292-300. PubMed ID: 26028656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crinkling of epicardial defibrillator patches. A common and serious problem.
    Molina JE; Benditt DG; Adler S
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):258-64. PubMed ID: 7609549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensing/pacing lead complications with a newer generation implantable cardioverter-defibrillator: worldwide experience from the Guardian ATP 4210 clinical trial.
    Stambler BS; Wood MA; Damiano RJ; Greenway PS; Smutka ML; Ellenbogen KA
    J Am Coll Cardiol; 1994 Jan; 23(1):123-32. PubMed ID: 8277070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of failure of transvenous implantable cardioverter-defibrillator leads.
    Borleffs CJ; van Erven L; van Bommel RJ; van der Velde ET; van der Wall EE; Bax JJ; Rosendaal FR; Schalij MJ
    Circ Arrhythm Electrophysiol; 2009 Aug; 2(4):411-6. PubMed ID: 19808497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on small-diameter implantable cardioverter-defibrillator leads performance.
    van Rees JB; van Welsenes GH; Borleffs CJ; Thijssen J; van der Velde ET; van der Wall EE; van Erven L; Schalij MJ
    Pacing Clin Electrophysiol; 2012 Jun; 35(6):652-8. PubMed ID: 22352338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Necessity for surgical revision of defibrillator leads implanted long-term: causes and management.
    Eckstein J; Koller MT; Zabel M; Kalusche D; Schaer BA; Osswald S; Sticherling C
    Circulation; 2008 May; 117(21):2727-33. PubMed ID: 18490526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective long-term evaluation of Optim-insulated (Riata ST Optim and Durata) implantable cardioverter-defibrillator leads.
    Cairns JA; Epstein AE; Rickard J; Connolly SJ; Buller C; Wilkoff BL; Pogue J; Themeles E; Healey JS
    Heart Rhythm; 2014 Dec; 11(12):2156-62. PubMed ID: 25131665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malfunction of implantable cardioverter defibrillators placed by a nonthoracotomy approach: frequency of malfunction and value of chest radiography in determining cause.
    Drucker EA; Brooks R; Garan H; Sweeney MO; Ruskin JM; McGovern BA; Miller SW
    AJR Am J Roentgenol; 1995 Aug; 165(2):275-9. PubMed ID: 7618539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable implantable cardioverter-defibrillator implanted with or without thoracotomy: an international multicenter study. PCD Investigator Group.
    J Am Coll Cardiol; 1994 Jun; 23(7):1521-30. PubMed ID: 8195508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failures of epicardial and transvenous leads for implantable cardioverter defibrillators.
    Mattke S; Müller D; Markewitz A; Kaulbach H; Schmöckel M; Dorwarth U; Hoffmann E; Steinbeck G
    Am Heart J; 1995 Nov; 130(5):1040-4. PubMed ID: 7484734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of ICD lead related complications during long-term follow-up: comparison of epicardial and endocardial electrode systems.
    Korte T; Jung W; Spehl S; Wolpert C; Moosdorf R; Manz M; Lüderitz B
    Pacing Clin Electrophysiol; 1995 Nov; 18(11):2053-61. PubMed ID: 8552520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years.
    Kleemann T; Becker T; Doenges K; Vater M; Senges J; Schneider S; Saggau W; Weisse U; Seidl K
    Circulation; 2007 May; 115(19):2474-80. PubMed ID: 17470696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure.
    Hauser RG; Hayes DL
    Heart Rhythm; 2009 May; 6(5):605-10. PubMed ID: 19285920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of impedance monitoring to prevent adverse clinical events caused by fracture of a recalled high-voltage implantable cardioverter-defibrillator lead.
    Kallinen LM; Hauser RG; Lee KW; Almquist AK; Katsiyiannis WT; Tang CY; Melby DP; Gornick CC
    Heart Rhythm; 2008 Jun; 5(6):775-9. PubMed ID: 18534361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and management of an implantable cardioverter defibrillator lead failure: incidence and clinical implications.
    Ellenbogen KA; Wood MA; Shepard RK; Clemo HF; Vaughn T; Holloman K; Dow M; Leffler J; Abeyratne A; Verness D
    J Am Coll Cardiol; 2003 Jan; 41(1):73-80. PubMed ID: 12570948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensing lead insulation fractures following implantable cardioverter-defibrillator placement.
    Tedder M; Anstadt MP; Tedder SD; Revishvili AS; Hegde SS; Lowe JE
    ASAIO J; 1993; 39(3):M711-4. PubMed ID: 8268630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transvenous implantable cardioverter-defibrillator lead reliability: implications for postmarket surveillance.
    Kramer DB; Hatfield LA; McGriff D; Ellis CR; Gura MT; Samuel M; Retel LK; Hauser RG
    J Am Heart Assoc; 2015 May; 4(6):e001672. PubMed ID: 26025935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downloadable algorithm to reduce inappropriate shocks caused by fractures of implantable cardioverter-defibrillator leads.
    Swerdlow CD; Gunderson BD; Ousdigian KT; Abeyratne A; Stadler RW; Gillberg JM; Patel AS; Ellenbogen KA
    Circulation; 2008 Nov; 118(21):2122-9. PubMed ID: 18981299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of Lead Failure by Recall Status and Manufacturer: Results From the Pacemaker and Implantable Defibrillator Leads Survival Study ("PAIDLESS").
    Schwarzwald SN; Kersten DJ; Shaikh ZA; Needelman BS; Feldman AM; Germano J; Islam S; Cohen TJ
    J Invasive Cardiol; 2018 Apr; 30(4):147-151. PubMed ID: 29610446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.